Zhongwei Zhao1, Xiangyu Tang2, Kai Song2, Xiang Li3, Yonggang Zhang2. 1. Department of Orthopaedics, Chinese People's Liberation Army General Hospital 28 Fuxing Road, Beijing 100835, China ; Department of Orthopaedics, The Puren Hospital of Beijing 100 Chongwai Street, Beijing 100062, China. 2. Department of Orthopaedics, Chinese People's Liberation Army General Hospital 28 Fuxing Road, Beijing 100835, China. 3. Department of Spine Surgery, Beijing Bo'ai Hospital, China Rehabilitation Research Center Beijing 100068, China.
Abstract
OBJECTIVE: As a proinflammatory cytokine, TNF-α is associated with increased risk of osteosarcoma (OS). Our study aimed to explore the association of TNF-α polymorphisms and OS susceptibility in the Han Chinese population. METHODS: 80 OS patients and 99 healthy people, matched on the age and sex, participated in the study. Genotyping was conducted by the method of polymerase chain reaction-restricted fragment length polymorphisms (PCR-RFLP). Then logistic regression was used to evaluate the effects of TNF-α polymorphisms (-308 G/A and -238 G/A) on the pathology of OS. RESULTS: The frequency of AA genotype in -308 G/A locus in the cases was significantly higher than that of the healthy group (20.0% vs. 6.1%). Patients with OS were more likely to possess AA genotype of -308 G/A locus (OR=4.00, 95% CI=1.41-11.38). For the patients with A allele, the risk for OS increased 0.62 fold (OR=1.62, 95% CI=1.04-2.50). There was no remarkable relationship of -238 G/A polymorphisms and OS susceptibility. In addition, we found that patients with G-A and A-A haplotypes was much higher in the cases than that of control group (68.0% and 25.0%, 53.0% and 38.9%, respectively). A-G haplotype appeared to increase the risk for OS (OR=1.93, 95% CI=1.13-2.94). CONCLUSION: The AA genotype of -308 G/A locus of TNF-α gene was a risk factor for OS, however there was no correlation between -238 G/A of TNF-α and OS.
OBJECTIVE: As a proinflammatory cytokine, TNF-α is associated with increased risk of osteosarcoma (OS). Our study aimed to explore the association of TNF-α polymorphisms and OS susceptibility in the Han Chinese population. METHODS: 80 OS patients and 99 healthy people, matched on the age and sex, participated in the study. Genotyping was conducted by the method of polymerase chain reaction-restricted fragment length polymorphisms (PCR-RFLP). Then logistic regression was used to evaluate the effects of TNF-α polymorphisms (-308 G/A and -238 G/A) on the pathology of OS. RESULTS: The frequency of AA genotype in -308 G/A locus in the cases was significantly higher than that of the healthy group (20.0% vs. 6.1%). Patients with OS were more likely to possess AA genotype of -308 G/A locus (OR=4.00, 95% CI=1.41-11.38). For the patients with A allele, the risk for OS increased 0.62 fold (OR=1.62, 95% CI=1.04-2.50). There was no remarkable relationship of -238 G/A polymorphisms and OS susceptibility. In addition, we found that patients with G-A and A-A haplotypes was much higher in the cases than that of control group (68.0% and 25.0%, 53.0% and 38.9%, respectively). A-G haplotype appeared to increase the risk for OS (OR=1.93, 95% CI=1.13-2.94). CONCLUSION: The AA genotype of -308 G/A locus of TNF-α gene was a risk factor for OS, however there was no correlation between -238 G/A of TNF-α and OS.
Authors: S Beissert; M Bergholz; I Waase; G Lepsien; A Schauer; K Pfizenmaier; M Krönke Journal: Proc Natl Acad Sci U S A Date: 1989-07 Impact factor: 11.205
Authors: Caroline H Arnott; Kate A Scott; Robert J Moore; Alan Hewer; David H Phillips; Peter Parker; Frances R Balkwill; David M Owens Journal: Oncogene Date: 2002-07-18 Impact factor: 9.867
Authors: G Bouma; B Xia; J B Crusius; G Bioque; I Koutroubakis; B M Von Blomberg; S G Meuwissen; A S Peña Journal: Clin Exp Immunol Date: 1996-03 Impact factor: 4.330
Authors: Lucas Rafael Lopes; Vitor Almeida Ribeiro de Miranda; João Antonio Matheus Guimarães; Gabriel Garcez de Araujo Souza; Victor Soares Wainchtock; João Alves Grangeiro Neto; Rodrigo de Araújo Goes; Jamila Alessandra Perini Journal: BMC Sports Sci Med Rehabil Date: 2021-05-13